Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?-Reference-Cited by-同舟云学术

Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?

Published:2007-03-31 Issue:5 Volume:7 Page:501-507
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

BATE C. M.,BOOTH S. N.,CROWE J. P.,HEPWORTH-JONES B.,TAYLOR M. D.,RICHARDSON P. D. I.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1993.tb00125.x/fullpdf

Reference12 articles.

1. Omeprazole: overview and opinion;Holt;Dig Dis Sci,1991

2. A comparison of omeprazole and cimetidine in refiux oesophagitis: symptomatic, endoscopic and histological evaluations;Bate;Gut,1990

3. Refiux oesophagitis resolves more rapidly with omeprazole 20 mg once daily than with ranitidine 150 mg twice daily: Omeprazole 40 mg once daily provides further benefit in unresponsive patients;Bate;Br J Clin Res,1991

4. Cost-effectiveness of omeprazole in the treatment of refiux oesophagitis;Bate;Br J Med Econ,1991

5. A one year model for the costeffectiveness of treating reflux oesophagitis;Bate;Br J Med Econ,1992

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transoral incisionless fundoplication is cost-effective for treatment of gastroesophageal reflux disease;Endoscopy International Open;2022-07

2. The Discrepancy Between Subjective and Objective Clinical Endpoints in Gastroesophageal Reflux Disease;Journal of Clinical Gastroenterology;2022-03-24

3. Antiulcer Drugs;Ullmann's Encyclopedia of Industrial Chemistry;2012-10-15

4. Editorial: Healing Erosive Esophagitis With a Proton Pump Inhibitor: The More the Merrier?;American Journal of Gastroenterology;2012-04

5. Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis - a mixed treatment comparison of randomized controlled trials;Alimentary Pharmacology & Therapeutics;2009-09